ENDOCRINOLOGY

Managing Diabetes in People with Foot Complications

Apr 14, 2017 by in ENDOCRINOLOGY Comments Off on Managing Diabetes in People with Foot Complications

Oral agent classes (e.g., denotes other agents in same class available) Biguanides (metformin) Sulphonylureas (e.g., gliclazide) Thiazolidinediones (pioglitazone) Alpha glucosidase inhibitors (acarbose) Meglitinides (e.g., repaglinide) Dipeptidyl peptidase-4 (DPP-4) inhibitors (e.g.,…

read more

Foot Complications in Diabetes: The Problem

Apr 14, 2017 by in ENDOCRINOLOGY Comments Off on Foot Complications in Diabetes: The Problem

© Springer-Verlag London 2015Clifford P. Shearman (ed.)Management of Diabetic Foot Complications10.1007/978-1-4471-4525-7_1 1. Foot Complications in Diabetes: The Problem Clifford P. Shearman1   (1) Department of Vascular Surgery, University of Southampton, University Hospital of Southampton NHS Foundation Trust,…

read more

Cholesterol Absorption Inhibitors (Ezetimibe) and Bile Acid Binding Resins (Colesevelam HCl) as Therapy for Dyslipidemia in Patients with Diabetes Mellitus

Apr 14, 2017 by in ENDOCRINOLOGY Comments Off on Cholesterol Absorption Inhibitors (Ezetimibe) and Bile Acid Binding Resins (Colesevelam HCl) as Therapy for Dyslipidemia in Patients with Diabetes Mellitus

Fig. 22.1 Title: Adiposopathy: Simplified relationship between pathogenic adipose tissue and cardiovascular disease [2]. Adiposopathy is promoted by unhealthy nutrition and a sedentary lifestyle in genetically and environmentally predisposed individuals….

read more

The PPAR System in Diabetes

Apr 14, 2017 by in ENDOCRINOLOGY Comments Off on The PPAR System in Diabetes

(1) ClinSciences, 10 avenue Victor Hugo, 21000 Dijon, France     Jean Claude Ansquer Email: jean-claude.ansquer@clinsciences.fr Abstract Peroxisome proliferator-activated receptors (PPARs), with three existing isoforms (PPAR α, PPAR β/δ, and PPAR γ), belong…

read more
Get Clinical Tree app for offline access